| 000 | 01806 a2200553 4500 | ||
|---|---|---|---|
| 005 | 20250514180924.0 | ||
| 264 | 0 | _c20040311 | |
| 008 | 200403s 0 0 eng d | ||
| 022 | _a1095-9203 | ||
| 024 | 7 |
_a10.1126/science.1088757 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aChamberlain, Joel R | |
| 245 | 0 | 0 |
_aGene targeting in stem cells from individuals with osteogenesis imperfecta. _h[electronic resource] |
| 260 |
_bScience (New York, N.Y.) _cFeb 2004 |
||
| 300 |
_a1198-201 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, P.H.S. | ||
| 650 | 0 | 4 | _aAlleles |
| 650 | 0 | 4 | _aAnimals |
| 650 | 0 | 4 |
_aBone Marrow Cells _xphysiology |
| 650 | 0 | 4 | _aCell Differentiation |
| 650 | 0 | 4 | _aCells, Cultured |
| 650 | 0 | 4 |
_aCollagen Type I _xchemistry |
| 650 | 0 | 4 |
_aDependovirus _xgenetics |
| 650 | 0 | 4 | _aGene Targeting |
| 650 | 0 | 4 | _aGenetic Therapy |
| 650 | 0 | 4 | _aGenetic Vectors |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aKanamycin Kinase _xgenetics |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 |
_aMesenchymal Stem Cells _xphysiology |
| 650 | 0 | 4 | _aMice |
| 650 | 0 | 4 | _aOsteogenesis |
| 650 | 0 | 4 |
_aOsteogenesis Imperfecta _xgenetics |
| 650 | 0 | 4 | _aPoint Mutation |
| 650 | 0 | 4 | _aRecombination, Genetic |
| 650 | 0 | 4 | _aStem Cell Transplantation |
| 700 | 1 | _aSchwarze, Ulrike | |
| 700 | 1 | _aWang, Pei-Rong | |
| 700 | 1 | _aHirata, Roli K | |
| 700 | 1 | _aHankenson, Kurt D | |
| 700 | 1 | _aPace, James M | |
| 700 | 1 | _aUnderwood, Robert A | |
| 700 | 1 | _aSong, Kit M | |
| 700 | 1 | _aSussman, Michael | |
| 700 | 1 | _aByers, Peter H | |
| 700 | 1 | _aRussell, David W | |
| 773 | 0 |
_tScience (New York, N.Y.) _gvol. 303 _gno. 5661 _gp. 1198-201 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1126/science.1088757 _zAvailable from publisher's website |
| 999 |
_c14697917 _d14697917 |
||